EyeArt Autonomous AI System Cleared for Diabetic Retinopathy Screening
EyeArt is the first FDA-cleared AI technology for autonomous detection of more than mild diabetic retinopathy and vision-threatening diabetic retinopathy.
Diagnostic Testing
Seven States Join Pact to Speed COVID-19 Testing
Bipartisan plan illustrates just how bad testing delays are across the country
USPSTF Still Advises Against Carotid Artery Stenosis Screening
Harms of screening for asymptomatic carotid artery stenosis outweigh benefits in general population.
Respiratory Sampling Strategies for Detecting SARS-CoV-2 Compared
Sputum sampling was found to be a valuable method for diagnosing and monitoring patients with coronavirus disease 2019 (COVID-19), according to a recent systematic review and meta-analysis published in EBioMedicine.
Pooled Sampling Approved for COVID-19 Test
Sample pooling allows for more people to be tested quickly using fewer testing resources.
Symptom-Based Testing Not Adequate for Detecting COVID-19
Universal testing increased the total number of detected COVID-19 cases from 153 to 507 across all sites.
Pap/HPV Cotesting Better for Cervical Cancer Screening in Over 30s
Nondetection rate is 13.1% for cotesting, higher when testing is done >12 months prediagnosis.
USPSTF Advises Annual Low-Dose CT Lung Screening for High-Risk Individuals
Annual CT screening recommended for those aged 50 to 80 years at high risk due to smoking history.
FBI Warns of Scammers Selling Fake COVID-19 Antibody Tests
Consumers can protect themselves by checking FDA website for a list of approved antibody tests, testing companies
Testing for Antibodies to SARS-CoV-2: Timing Important for Accuracy
Serology tests were better at detecting the presence of antibodies to the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in patients when they were tested 15 to 35 days post-symptom onset, according to the findings of a recently published review on the Cochrane Database of Systematic Reviews.
